| OSAKA, Japan - Friday, January 8th 2016 [ME NewsWire]
(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TOKYO: 4502) ("Takeda") today announced that Christophe Weber, President and Chief Executive Officer of Takeda, will make a formal presentation on January 12, local time, at the 34th Annual J.P. Morgan Healthcare Conference held in San Francisco, California. The presentation will be followed by a Q&A session.
To view the full report and tables please click here.
About Takeda Pharmaceutical Company Limited
Located in Osaka, Japan, Takeda (TOKYO: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.
Contacts
Media Contacts:
Takeda Pharmaceutical Company Limited
Tsuyoshi Tada, +81 3-3278-2417
tsuyoshi.tada@takeda.com
Investor Contacts:
Takeda Pharmaceutical Company Limited
Noriko Higuchi, +81 3-3278-2306
noriko.higuchi@takeda.com
Permalink: http://www.me-newswire.net/news/16762/en
|
